Evidence map›Paper›PMID 36838649›Full record

ArticleMolecules (Basel, Switzerland)2023

Synthesis of Novel Benzo[

Larisa N Kulikova, Ghulam Reza Raesi, Daria D Levickaya, Rosa Purgatorio, Gabriella La Spada, Marco Catto, Cosimo D Altomare, Leonid G Voskressensky

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Investigation on NovelMolecules (Basel, Switzerland) · 2023
    Article
  4. Chemical and Biological Evaluation of Novel 1International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Larisa N KulikovaOrganic Chemistry Department, Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya St. 6., 117198 Moscow, Russia.ORCID 0000-0001-5111-8111
Ghulam Reza RaesiOrganic Chemistry Department, Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya St. 6., 117198 Moscow, Russia.
Daria D LevickayaOrganic Chemistry Department, Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya St. 6., 117198 Moscow, Russia.
Rosa PurgatorioDepartment of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125 Bari, Italy.ORCID 0000-0003-1002-5087
Gabriella La SpadaDepartment of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125 Bari, Italy.
Marco CattoDepartment of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125 Bari, Italy.ORCID 0000-0002-8411-304X
Cosimo D AltomareDepartment of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125 Bari, Italy.ORCID 0000-0001-5016-5805
Leonid G VoskressenskyOrganic Chemistry Department, Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya St. 6., 117198 Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, 2-alkyl-10-chloro-1,2,3,4-tetrahydrobenzo[

Indexed as

Monoamine Oxidase InhibitorsPargylineMonoamine OxidaseNaphthyridinesStructure-Activity RelationshipMonoamine OxidaseMonoamine Oxidase InhibitorsNaphthyridinesPargylineactivated alkynesAlzheimer’s diseasebenzonaphthyridineMAO inhibitors

Identifiers

PMID36838649
PMCPMC9962805

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.